SCHEMBL16388285

SCHEMBL16388285

FCc1ccc(F)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.45
DAO P14920 1/20 0.41
PNMT P11086 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
RPA1 P27694 1/20 0.40
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SOS1 Q07889 1/20 0.39
IDO1 P14902 1/20 0.38
PLA2G1B P04054 2/20 0.38
ATG4B Q9Y4P1 2/20 0.38
CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1503218 0.81 PIK3CA (0.45) PIK3CADAOPNMTTAAR1HDAC3
SCHEMBL9788481 0.80 IDO1 (0.58) PNMTTAAR1IDO1TSHRCYP1A2
SCHEMBL17552701 0.79 PIK3CA (0.44) PIK3CADAOPNMTTAAR1HDAC3
SCHEMBL2195620 0.79 PIK3CA (0.47) PIK3CADAOHDAC3HDAC1HDAC2
SCHEMBL42420 0.79 PIK3CA (0.44) PIK3CADAOPNMTTAAR1HDAC3
SCHEMBL257081 0.79 TSHR (0.44) PIK3CADAOPNMTTAAR1HDAC3
SCHEMBL5650950 0.79 PIK3CA (0.47) PIK3CADAOPNMTTAAR1HDAC3
SCHEMBL151278 0.79 PIK3CA (0.44) PIK3CADAOPNMTTAAR1HDAC3
SCHEMBL42421 0.79 CSNK2A1 (0.50) PIK3CAPNMTTAAR1SLC6A4SLC6A3
SCHEMBL8220202 0.79 PIK3CA (0.44) PIK3CADAOPNMTTAAR1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015002994-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-01-08 WO disclosed